{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:38:54Z","timestamp":1787027934758,"version":"build-2736575974"},"reference-count":42,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background and Clinical Significance: Prostate cancer (PCa) is among the most commonly diagnosed malignancies in men worldwide. While bone and lymph nodes are the most frequent metastatic sites, prostate cancer cells have the potential to spread to virtually any organ, including the pleura, which is an exceedingly rare initial site of presentation that can mimic mesothelioma or primary lung cancer. Case Presentation: We describe a 77-year-old man who presented with exertional dyspnea and intermittent cough, initially suggesting a cardiopulmonary etiology. Imaging revealed multiple pleural nodules and an extensive right-sided pleural effusion. Despite a borderline serum prostate-specific antigen (PSA) level of 2.91 ng\/mL, histopathology and immunohistochemistry of pleural biopsies confirmed metastatic prostate adenocarcinoma. Subsequent imaging identified a PIRADS 5 lesion in the prostate, and a biopsy confirmed ISUP Grade Group 5 disease (Gleason score 4 + 5 = 9). A bone scan showed no skeletal metastases, and a contrast-enhanced CT of the abdomen found no additional metastatic lesions. The patient was started on androgen deprivation therapy followed by abiraterone. This case underscores the diagnostic challenge posed by atypical metastatic presentations of prostate cancer. Low or moderately elevated PSA can obscure suspicion of prostate origin, especially with pleural-based lesions suggestive of mesothelioma. Immunohistochemical markers, including androgen receptors, AMACR, and Prostein, are critical for accurate diagnosis. Conclusions: Clinicians must maintain a high index of suspicion for prostate cancer in older men with unexplained pleural effusions, nodules, or masses, even with low-normal PSA levels. Early recognition and prompt treatment can improve outcomes, despite the rarity and aggressiveness of pleural metastases.<\/jats:p>","DOI":"10.3390\/diagnostics15060666","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T09:36:24Z","timestamp":1741599384000},"page":"666","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pleural Metastasis as an Initial Presentation of Prostate Cancer: Case Report and Literature Review"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3710-9037","authenticated-orcid":false,"given":"Katarzyna","family":"Skrobisz","sequence":"first","affiliation":[{"name":"Department of Radiology, Medical University of Gda\u0144sk, 17 Smoluchowskiego St., 80-214 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7527-3692","authenticated-orcid":false,"given":"Kevin","family":"Miszewski","sequence":"additional","affiliation":[{"name":"Department of Urology, Medical University of Gda\u0144sk, 17 Smoluchowskiego St., 80-214 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Miszewska","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Medical University of Gda\u0144sk, 17 Smoluchowskiego St., 80-214 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9291-3928","authenticated-orcid":false,"given":"Micha\u0142","family":"Bie\u0144kowski","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical University of Gda\u0144sk, 17 Smoluchowskiego St., 80-214 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Matuszewski","sequence":"additional","affiliation":[{"name":"Department of Urology, Medical University of Gda\u0144sk, 17 Smoluchowskiego St., 80-214 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9200-1320","authenticated-orcid":false,"given":"Micha\u0142","family":"Studniarek","sequence":"additional","affiliation":[{"name":"Department of Radiology, Medical University of Gda\u0144sk, 17 Smoluchowskiego St., 80-214 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.33588","article-title":"Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2020","volume":"149","author":"Ferlay","year":"2021","journal-title":"Int. J. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2214\/AJR.11.7533","article-title":"Atypical metastases from prostate cancer: 10-year experience at a single institution","volume":"199","author":"Vinjamoori","year":"2012","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1053\/hp.2000.6698","article-title":"Metastatic patterns of prostate cancer: An autopsy study of 1,589 patients","volume":"31","author":"Bubendorf","year":"2000","journal-title":"Hum. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/1097-0142(19860815)58:4<985::AID-CNCR2820580432>3.0.CO;2-I","article-title":"Metastatic behavior of prostate cancer: Cluster analysis of patterns with respect to estrogen treatment","volume":"58","author":"Moore","year":"1986","journal-title":"Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1259\/bjr.72.862.10673942","article-title":"Features of unusual metastases from prostate cancer","volume":"72","author":"Long","year":"1999","journal-title":"Br. J. Radiol."},{"key":"ref_7","first-page":"31","article-title":"Pulmonary metastases from prostate cancer","volume":"91","author":"Apple","year":"1964","journal-title":"J. Urol."},{"key":"ref_8","first-page":"24","article-title":"Malignant pleural effusion from prostate adenocarcinoma","volume":"13","author":"Knight","year":"2014","journal-title":"Respir. Med. Case Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/1759-7714.12001","article-title":"Case of pleural metastasis of prostate cancer","volume":"4","author":"Yasuda","year":"2013","journal-title":"Thorac. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4132\/jptm.2018.05.08","article-title":"Malignant pleural effusion due to metastatic prostate cancer: Cytologic features and immunocytochemical findings","volume":"52","author":"Jeon","year":"2018","journal-title":"J. Pathol. Transl. Med."},{"key":"ref_11","first-page":"439","article-title":"Low PSA and high-grade prostate cancer: An emerging clinical entity?","volume":"177","author":"Whittemore","year":"2007","journal-title":"J. Urol."},{"key":"ref_12","first-page":"83","article-title":"Metastatic prostatic carcinoma with normal prostate-specific antigen levels","volume":"26","author":"Shepherd","year":"1992","journal-title":"Scand. J. Urol. Nephrol."},{"key":"ref_13","first-page":"2587","article-title":"Pleural effusion in a patient with advanced prostate cancer: A case report and short literature review","volume":"11","author":"Nikolaidis","year":"2016","journal-title":"Oncol. Lett."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"308A","DOI":"10.1378\/chest.1826362","article-title":"Isolated pleural involvement in recurrent metastatic prostate cancer: A case report","volume":"145","author":"Vakil","year":"2014","journal-title":"Chest"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/00000478-200306000-00007","article-title":"Cytoplasmic localization of alpha-methylacyl-CoA racemase is an immunohistochemical marker of prostatic carcinoma","volume":"27","author":"Zhou","year":"2003","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.eururo.2014.07.020","article-title":"Impact of the site of metastases on survival in patients with metastatic prostate cancer","volume":"68","author":"Gandaglia","year":"2015","journal-title":"Eur. Urol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1159\/000442045","article-title":"Prostate cancer: Cases of rare presentation and rare metastasis","volume":"8","author":"Mandaliya","year":"2015","journal-title":"Case Rep. Oncol."},{"key":"ref_18","first-page":"730","article-title":"Breast metastasis from castrate-resistant prostatic adenocarcinoma mimicking as a second primary: A case report","volume":"11","author":"Lima","year":"2018","journal-title":"Case Rep. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1097\/01.ju.0000056706.88960.7c","article-title":"Second primary cancers in men with prostate cancer: An increased risk of male breast cancer","volume":"169","author":"Thellenberg","year":"2003","journal-title":"J. Urol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.3816\/CBC.2010.n.013","article-title":"Metastatic prostatic adenocarcinoma mimicking inflammatory breast carcinoma: A case report","volume":"10","author":"Njiaju","year":"2010","journal-title":"Clin. Breast Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/archopht.1988.01060140567024","article-title":"Orbital metastases from prostate carcinoma","volume":"106","author":"Boldt","year":"1988","journal-title":"Arch. Ophthalmol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0161-6420(93)31413-2","article-title":"Metastatic prostate cancer to the optic canal","volume":"100","author":"Kattah","year":"1993","journal-title":"Ophthalmology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.eururo.2013.09.024","article-title":"The prognostic importance of metastatic site in men with metastatic castration-resistant prostate cancer","volume":"65","author":"Pond","year":"2014","journal-title":"Eur. Urol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.18632\/oncotarget.23366","article-title":"Prognosis of men with penile metastasis and malignant priapism: A systematic review","volume":"9","author":"Cocci","year":"2018","journal-title":"Oncotarget"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000258964","article-title":"A case of bilateral adrenal and pleural metastases from prostate cancer","volume":"2","author":"Kawahara","year":"2009","journal-title":"Case Rep. Oncol."},{"key":"ref_26","first-page":"690","article-title":"Massive pleural effusion due to metastasis of prostate cancer","volume":"60","author":"Gouvea","year":"2011","journal-title":"West. Indian. Med. J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.18332\/pne\/188870","article-title":"EBUS-TBNA pleural biopsy reveals prostate cancer metastasis: A rare case report and review of the literature","volume":"37","author":"Sampsonas","year":"2024","journal-title":"Pneumon"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1046\/j.1442-2042.1999.06125.x","article-title":"Surgical excision of a metastatic adrenal lesion in a patient with prostatic cancer","volume":"6","author":"Sakamoto","year":"1999","journal-title":"Int. J. Urol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1177\/030089169007600622","article-title":"Addison\u2019s disease secondary to prostatic carcinoma. A case report","volume":"76","author":"Navarro","year":"1990","journal-title":"Tumori"},{"key":"ref_30","first-page":"157","article-title":"Bilateral adrenal metastases from prostatic carcinoma during chemoendocrine therapy","volume":"57","author":"Ishii","year":"2003","journal-title":"Rinsho Hinyokika"},{"key":"ref_31","first-page":"769","article-title":"Prostate cancer with multiple pulmonary and pleural metastases: A case report","volume":"58","author":"Takagi","year":"2004","journal-title":"Rinsho Hinyokika"},{"key":"ref_32","first-page":"487","article-title":"Massive pleural effusion from prostate cancer metastasis: A rare case and review of the literature","volume":"174","author":"Nikolopoulos","year":"2015","journal-title":"Gazz. Med. Ital. Arch. Sci. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4172\/2161-105X.1000135","article-title":"Metastasis of prostate cancer to pleura","volume":"3","author":"Singh","year":"2013","journal-title":"J. Pulmon Resp. Med."},{"key":"ref_34","first-page":"374A","article-title":"Transudative pleural effusion from metastatic prostate cancer","volume":"142","author":"Knight","year":"2012","journal-title":"Chest"},{"key":"ref_35","first-page":"19","article-title":"Prostate cancer presenting as malignant pleural effusion with normal PSA","volume":"7","author":"Percarpio","year":"2016","journal-title":"Urol. Case Rep."},{"key":"ref_36","first-page":"147","article-title":"Low PSA, high-grade prostate cancer","volume":"17","author":"Jewett","year":"1999","journal-title":"Semin. Urol. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Terry, S., and Beltran, H. (2014). The many faces of neuroendocrine differentiation in prostate cancer progression. Front. Oncol., 4.","DOI":"10.3389\/fonc.2014.00060"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000112221","article-title":"Diagnostic work-up of pleural effusions","volume":"75","author":"Froudarakis","year":"2008","journal-title":"Respiration"},{"key":"ref_39","first-page":"1364","article-title":"The IMAAGEN study: Effect of abiraterone acetate and prednisone on PSA and radiographic progression in patients with nonmetastatic castration-resistant prostate cancer","volume":"36","author":"Ryan","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1056\/NEJMoa1704174","article-title":"Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer","volume":"377","author":"Fizazi","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1056\/NEJMoa040720","article-title":"Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer","volume":"351","author":"Tannock","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1002\/(SICI)1097-0142(19991201)86:11<2301::AID-CNCR18>3.0.CO;2-D","article-title":"Brain metastasis from prostate carcinoma: Antemortem recognition and outcome after treatment","volume":"86","author":"McCutcheon","year":"1999","journal-title":"Cancer"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/6\/666\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:49:48Z","timestamp":1760028588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/6\/666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["diagnostics15060666"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics15060666","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]}}}